Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine
10:28am, Tuesday, 31'st Jan 2023
Yahoo Finance Live anchors Julie Hyman, Brian Sozzi, and Brad Smith discuss fourth-quarter earnings for Pfizer.
Pfizer Shares Dismal Sales Outlook Despite Record Revenue
10:18am, Tuesday, 31'st Jan 2023
Pfizer Inc. (NYSE:PFE) is down 0.8% to trade at $43.22, despite reporting better-than-anticipated fourth-quarter earnings of $1.14 per share, in addition to record revenue of $100.3 billion in 2022.
Biggest Earnings Week of the Season: Key Stocks to Watch
10:15am, Tuesday, 31'st Jan 2023
This week is undoubtedly the most important week of earnings season. Andrew Rocco highlights key industries to watch including big tech, biotech, and energy.
Pfizer Expects Covid Vaccine And Pill Revenues Will Fall 60% In 2023
09:44am, Tuesday, 31'st Jan 2023
Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer's core products combatting Covid-19.
Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates
09:30am, Tuesday, 31'st Jan 2023
Pfizer (PFE) delivered earnings and revenue surprises of 10.68% and 0.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Pfizer beats EPS estimates; stock falls on lower yearly guidance
09:00am, Tuesday, 31'st Jan 2023
CNBC's Meg Tirrell reports on Pfizer's quarterly earnings results.
Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022
08:02am, Tuesday, 31'st Jan 2023
The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.
Pfizer tops profit expectations but gives downbeat outlook, as COVID product sales set to tumble
07:05am, Tuesday, 31'st Jan 2023
Shares of Pfizer Inc. PFE, -0.55% dropped 2.2% toward a 3 1/2-month low in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that topped expectations but revenue and the f
Markets Close at Session Lows Ahead of Massive Data, Fed
07:34pm, Monday, 30'th Jan 2023
The Dow dropped -260 points, -0.77%, and it was the outperformer. The S&P 500 was -1.30% on the day, while the Nasdaq sank -227 points, -1.96%.
Investing in Cancer Stocks
10:43am, Monday, 30'th Jan 2023
Learn about some of the leading cancer stocks in the U.S stock market this year.
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
09:56am, Monday, 30'th Jan 2023
The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday. The post The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs
Longevity Startup VitaDAO Raises $4.1m, Backed By Pfizer, Balaji Srinivasan
06:00am, Monday, 30'th Jan 2023
The web transformed life as we know it, allowing new ways of working, solving problems, and distributing currency.
Pfizer Facing Profit Drop After Record Year as COVID Vaccine Demand Fades
05:00pm, Friday, 27'th Jan 2023
Three analysts have downgraded the drug giant's stock ahead of Tuesday's quarterly results and annual guidance.
The Cash King In Big Pharma: Pfizer (Rating Upgrade)
02:01pm, Friday, 27'th Jan 2023
Wall Street has gone downgrade happy on Pfizer in January, loudly complaining the end of the pandemic has arrived. What brokerage analysts are failing to appreciate is Pfizer now has the strongest bal
2 Large Cap Stocks To Watch In The Stock Market Today
09:37am, Friday, 27'th Jan 2023
Are these large cap stocks among the best to invest in currently?
